Drugs and biologicals
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00340
- Awardee
-
Invivoscribe, Inc. UEI R1EVMK8MEZS9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,955
Award facts
- Contract value 100% obligated
- $15,955.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Invivoscribe, Inc. for $15,955.00 on March 18, 2020, for drugs and biologicals with an ultimate completion date of April 30, 2020. The order carries no small business set-aside. Work is performed in San Diego, California. The contract is firm fixed price, reflecting a commercial purchase of specialized biological kits and reagents to support cancer research initiatives.
Quick answers
Who was awarded contract 75N91020P00340?
75N91020P00340 was awarded to Invivoscribe, Inc. by National Cancer Institute (National Institutes of Health) on March 18, 2020.
How much is contract 75N91020P00340 worth?
The government has obligated $15,955 on 75N91020P00340.
Was contract 75N91020P00340 competed?
The extent of competition for 75N91020P00340 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award